Zhejiang Xianju Pharmaceutical Co.,Ltd.
002332.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.67B
Close$
$7.08
19.1% downside
Current Fair Value
19.1% downsideOvervalued by 19.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.67 Billion |
|---|---|
| Enterprise Value | $7.76 Billion |
| Dividend Yield | $0.30 (3.42%) |
| Earnings per Share | $0.45 |
| Beta | 0.24 |
| Outstanding Shares | 971,251,904 |
Return
| Return on Equity | 6.47% |
|---|---|
| Return on Assets | 5.44% |
| Return on Invested Capital | 7.88% |
Valuation & Multiples
| P/E Ratio | 22.02 |
|---|---|
| PEG | -265.67 |
| Price to Sales | 2.92 |
| Price to Book Ratio | 1.46 |
| Enterprise Value to Revenue | 2.02 |
| Enterprise Value to EBIT | 15.86 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$1.04 B
Average shareholder expectationNext Earnings Call
Expected Date
October 26, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Xianju Pharmaceutical Co.,Ltd.
3,209 employees
CEO: Weihua Jin Zhejiang Xianju Pharmaceutical Co.,Ltd. is a global enterprise specializing in the production and distribution of steroidal and hormonal pharmaceutical products. Its offerings span active pharmaceutical ingredients (APIs), specifically s...